Oxford Biomedica's next CEO to start in March; Kåre Schultz ready to wrap up Teva tenure early
→ Frank Mathias is calling it quits as CEO of German CDMO Rentschler Biopharma, moving instead to UK gene and cell …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
